Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Leukemia × Razoxane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Cardiotoxicity 4 Lymphoma 3 Sarcoma 2 Neuroblastoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleuropulmonary blastoma 1 Osteosarcoma 1 Lymphoma, Large-Cell, Anaplastic 1 Localized Extraskeletal Ewing Sarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Ganglioneuroblastoma 1 Burkitt Lymphoma 1

Interventions

Cytarabine 45 Cyclophosphamide 29 Methotrexate 28 Gene Expression Profiling 24 Daunorubicin 24 Flow Cytometry 21 Vincristine 19 Dexamethasone 17 Asparaginase 16 Mercaptopurine 15 Microarray Analysis 14 Filgrastim 14 Etoposide 14 Thioguanine 12 Radiotherapy 11 Prednisone 11 Leucovorin 11 Doxorubicin 11 pegaspargase 10 Polymerase Chain Reaction 10 Idarubicin 10 Gemtuzumab 10 Calcium Dobesilate 10 Peripheral Blood Stem Cell Transplantation 9 Hydrocortisone 9 Busulfan 9 Reverse Transcriptase Polymerase Chain Reaction 8 Mitoxantrone 8 Cytogenetic Analysis 8 Cyclosporine 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01230983 2013-06-06

T-Cell #4

Children's Oncology Group

Phase 3 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡